The impact of micronized progesterone on breast cancer risk: a systematic review

The 2017 hormone therapy position statement of The North American Menopause Society

(2017)   MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY

The impact of micronized progesterone on the endometrium: a systematic review

(2016) P. Stute et al.   CLIMACTERIC

2016 IMS Recommendations on women’s midlife health and menopause hormone therapy

(2016) R. J. Baber et al.   CLIMACTERIC

Estradiol therapy and breast cancer risk in perimenopausal and postmenopausal women: a systematic review and meta-analysis

(2016) Zhilan Yang et al.   GYNECOLOGICAL ENDOCRINOLOGY

Maintaining postreproductive health: A care pathway from the European Menopause and Andropause Society (EMAS)

(2016) Eleni Armeni et al.   MATURITAS

Vascular Effects of Early versus Late Postmenopausal Treatment with Estradiol

(2016) Howard N. Hodis et al.   NEW ENGLAND JOURNAL OF MEDICINE

Compounded bioidentical hormone therapy

(2015) JoAnn V. Pinkerton et al.   MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY

Diagnosis and management of menopause: summary of NICE guidance

(2015) G. Sarri et al.   BMJ-British Medical Journal

Diagnosis and management of menopause: summary of NICE guidance

(2015) G. Sarri et al.   BMJ-British Medical Journal

Arterial Imaging Outcomes and Cardiovascular Risk Factors in Recently Menopausal Women

(2014) S. Mitchell Harman et al.   ANNALS OF INTERNAL MEDICINE

Risk of breast cancer after stopping menopausal hormone therapy in the E3N cohort

(2014) Agnès Fournier et al.   BREAST CANCER RESEARCH AND TREATMENT

Think Twice Before Prescribing Custom-Compounded Bioidentical Hormone Therapy

(2014) JoAnn V. Pinkerton   JOURNAL OF WOMENS HEALTH

Systemic progesterone therapy—Oral, vaginal, injections and even transdermal?

(2014) Xiangyan Ruan et al.   MATURITAS

What are the concerns about custom-compounded “bioidentical” hormone therapy?

(2014) JoAnn V. Pinkerton   MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY

Updated 2013 International Menopause Society recommendations on menopausal hormone therapy and preventive strategies for midlife health

(2013) T. J. de Villiers et al.   CLIMACTERIC

Risk of Breast Cancer by Type of Menopausal Hormone Therapy: a Case-Control Study among Post-Menopausal Women in France

(2013) Emilie Cordina-Duverger et al.   PLoS One

Percutaneous estradiol/oral micronized progesterone has less-adverse effects and different gene regulations than oral conjugated equine estrogens/medroxyprogesterone acetate in the breasts of healthy womenin vivo

(2012) Daniel Murkes et al.   GYNECOLOGICAL ENDOCRINOLOGY

Relationship Between Mammographic Density and Breast Cancer Death in the Breast Cancer Surveillance Consortium

(2012) Gretchen L. Gierach et al.   JNCI-Journal of the National Cancer Institute

Progestogen levels, progesterone receptor gene polymorphisms, and mammographic density changes

(2011) Eunjung Lee et al.   MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY

Menopausal Hormone Therapy and Risk of Endometrial Carcinoma Among Postmenopausal Women in the European Prospective Investigation into Cancer and Nutrition

(2010) N. E. Allen et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Effects of percutaneous estradiol–oral progesterone versus oral conjugated equine estrogens–medroxyprogesterone acetate on breast cell proliferation and bcl-2 protein in healthy women

(2010) Daniel Murkes et al.   FERTILITY AND STERILITY

Estrogen-Progestagen Menopausal Hormone Therapy and Breast Cancer: Does Delay From Menopause Onset to Treatment Initiation Influence Risks?

(2009) Agnès Fournier et al.   JOURNAL OF CLINICAL ONCOLOGY

Transcriptional profiles of progestogen effects in the postmenopausal breast

(2008) Charles E. Wood et al.   BREAST CANCER RESEARCH AND TREATMENT

Parallel assessment of the impact of different hormone replacement therapies on breast density by radiologist- and computer-based analyses of mammograms

(2008) P. C. Pettersen et al.   CLIMACTERIC

Use of Different Postmenopausal Hormone Therapies and Risk of Histology- and Hormone Receptor–Defined Invasive Breast Cancer

(2008) Agnès Fournier et al.   JOURNAL OF CLINICAL ONCOLOGY